Nippon India Pharma Fund - Direct (G)
Nippon India Pharma Fund - Direct (G) Overview
Holdings Distribution
Top Holdings
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund - Direct (G) | 9.87% | 24.79% | 14.54% |
| Abakkus Small Cap Fund - Direct (G) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Reg (G) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Reg (IDCW) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Dir (G) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Dir (IDCW) | N/A | N/A | N/A |
Scheme Information
Nippon India Pharma Fund - Direct (G) was launched on 01/01/2013. The fund manages ₹7,898 Cr in assets. Its current expense ratio is 0.93%.
Fund Manager: Sailesh Raj Bhan
Returns Calculator
Calculate your investment growth with SIP or Lumpsum.
FAQs on Nippon India Pharma Fund - Direct (G)
The current expense ratio of Nippon India Pharma Fund - Direct (G) is 0.93%.
The AUM of Nippon India Pharma Fund - Direct (G) is ₹7,898 crore.
Log in to your investment platform, select the fund, enter units or amount, and confirm the redemption request.
Yes, Nippon India Pharma Fund - Direct (G) allows both SIP and lump sum investments.
The latest NAV is ₹601.70.
Minimum SIP starts from ₹100.
Redemption can be done via AMC website or your investment platform.
